FindTrial
Sign In

Use of Gene Xpert with other methods in diagnosis of Female Genital Tuberculosis

Evaluation of Gene Xpert as compared to conventional methods in diagnosis of genital TB among infertile women.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/09/009924
Enrollment
145
Registered
2017-09-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Female Patients who are infertile and have genital tuberculosis

Interventions

Intervention1: Use of traditional methods in diagnosis of Female Genital Tuberculosis: Study on Gene Xpert Sensitivity MTB/RIF in diagnosing female genital tuberculosis and assessing the Performance o

Sponsors

Central TB Division Ministry of Health and Family Welfare
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)All women found to have genital tuberculosis on gene Xpert analysis, clinical examination or on laparoscopy/hysteroscopy and confirmed with AFB culture, smear or histopathology 2)Patient willing to participate in the study

Exclusion criteria

Exclusion criteria: 1.Any gynecological malignancy. 2.Co-morbid conditions like HIV positive women. 3. Retreatment cases.

Design outcomes

Primary

MeasureTime frame
To show the Sensitivity and specificity of Gene Xpert MTB/RIF in Female Genital Tuberculosis Assessing the Performance of Gene Xpert MTB/RIF culture method vs Clinical correlation. Timepoint: After 2.5 years—

Secondary

MeasureTime frame
N/ATimepoint: N/A—

Countries

India

Contacts

Public ContactJ B SHARMA

AIIMS

jbsharma2000@gmail.com9868397309

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026